Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...

Among patients who experienced an early cardiovascular event, those treated with semaglutide had approximately 40% fewer ...

Discover how semaglutide reduces heart attack and stroke risk by 20% in overweight individuals, with benefits appearing ...

The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests. The drug, which contains the active ingredient semaglutide, works by reducing food ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

The SELECT trial, first conducted in 2023, demonstrated that semaglutide could reduce the risk of major heart events—such as ...

In people with diabetes, Farxiga drops A1C levels by roughly 0.6%, which is not a huge amount compared to other diabetes ...

A new study has found that a drug called semaglutide could help improve heart health in people who are overweight or obese, ...

Medications like semaglutide and liraglutide may help to reduce the risk for heart attacks, strokes, and other major adverse ...

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions in body weight and waist circumference.

Experts say the right diet may offer the same effects as Ozempic by curbing hunger and promoting steady weight loss.